CPIM
TTPH

Columbia Partners Investment Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Columbia Partners Investment Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-19,515
Closed -$18.5M – 394
2015
Q2 		$18.5M Sell
19,515
-3,395
-15% -$2.78M 1.14% 11
2015
Q1 		$16.8M Sell
22,910
-2,848
-11% -$2.14M 0.89% 17
2014
Q4 		$20.5M Buy
25,758
+865
+3% +$466K 1.06% 13
2014
Q3 		$9.93M Buy
24,893
+19,065
+327% +$5.11M 0.51% 70
2014
Q2 		$1.57M Sell
5,828
-9,406
-62% -$2.02M 0.07% 227
2014
Q1 		$3.32M Buy
+15,234
New +$4.25M 0.14% 183

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Columbia Partners Investment Management's TTPH Position: Q3 2015 in Review

Columbia Partners Investment Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2015, closing a stake of 19,515 shares — an estimated $18.5M sold.

Columbia Partners Investment Management first reported a position in TTPH in Q1 2014 and held it in 6 quarters. The position peaked at $20.5M in Q4 2014. 105 funds tracked by Wall St. Rank hold TTPH as of Q3 2015.

  • Columbia Partners Investment Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Columbia Partners Investment Management sold 19,515 Tetraphase Pharmaceuticals, Inc. shares in Q3 2015, an estimated $18.5M.
  • Columbia Partners Investment Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2014 and held it in 6 quarters.
  • Columbia Partners Investment Management's Tetraphase Pharmaceuticals, Inc. position peaked at $20.5M in Q4 2014.
  • 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2015.

Based on Columbia Partners Investment Management's 13F filing for Q3 2015, filed 10 Nov 2015.